ReviewExperimental & molecular medicine2017
Progress of antibody-based inhibitors of the HGF-cMET axis in cancer therapy.
Ki-Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled itcites it